ArticleCurrent protocols2026
MccB-catalyzed C-terminal Thioesterification for Protein Bioconjugation.
Article in Current protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- MccB-catalyzed C-terminal Thioesterification for Protein Bioconjugation.Current protocols · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Protein bioconjugation enables the installation of functional groups, probes, and payloads that cannot be genetically encoded, thereby enabling the study and manipulation of biological systems. An important class of intermediates in protein bioconjugation is C-terminal protein α-thioesters, which are kinetically stable yet thermodynamically activated as electrophiles for C-terminal functionalization. An ATP-driven, MccB-catalyzed enzymatic system for synthesis of protein C-terminal thioesters was recently developed to complement existing tools for chemical and intein-mediated synthesis of C-terminal thioesters. This system relies on modification of the target protein with a thioesterification C-terminal handle (TeCH tag) that is specifically recognized by MccB, enabling conversion of the C-terminal α-carboxylate to an α-thioester. Thioesters generated with the MccB/TeCH tag system can be integrated with well-established bioconjugation methods, including expressed protein ligation and enzyme-catalyzed expressed protein ligation, expanding the scope and versatility of this approach. This article outlines the steps for applying the MccB/TeCH tag system for epitope-specific C-terminal thioesterification and for the use of MccB-generated thioesters for expressed protein ligation and enzyme-catalyzed expressed protein ligation. © 2026 The Author(s). Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: MccB-catalyzed protein C-terminal thioesterification Alternate Protocol 1: MccB-catalyzed expressed protein ligation Alternate Protocol 2: Stepwise MccB-catalyzed protein C-terminal thioesterification followed by expressed protein ligation Support Protocol 1: Expression and purification of MccB Basic Protocol 2: MccB- and subtiligase-catalyzed expressed protein ligation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.